Targeting EphA3+ cells significantly reduced CCR10+EphA3+ as well as Lin– cells expressing CCR10, thereby confirming the expression of EphA3 on CCR10+ IPF cells. The gene discussed is EPHA3; the disease is idiopathic pulmonary fibrosis.